Have a personal or library account? Click to login
Comprehensive Assessment of Bacterial Pathogens Affecting Nile Tilapia and Their Control Strategies: Implications for Aquatic and Public Health Cover

Comprehensive Assessment of Bacterial Pathogens Affecting Nile Tilapia and Their Control Strategies: Implications for Aquatic and Public Health

Open Access
|Jan 2026

References

  1. Abayneh T., Colquhoun D.J., Sørum H. (2012). Multi-locus sequence analysis (MLSA) of Edwardsiella tarda isolates from fish. Vet. Microbiol., 158: 367–375.
  2. Abd El-latif A.M., Abd El-Gawad E.A., Soror E.I., Shourbela R.M., Zahran E. (2021). Dietary supplementation with miswak (Salva-dora persica) improves the health status of Nile tilapia and protects against Aeromonas hydrophila infection. Aquac. Rep., 19: 100594.
  3. Abd El-Rhman A.M., Khattab Y.A., Shalaby A.M. (2009). Micrococcus luteus and Pseudomonas species as probiotics for promoting the growth performance and health of Nile tilapia, Oreochromis niloticus. Fish Shellfish Immunol., 27: 175–180.
  4. Abdallah E.S.H., Metwally W.G.M., Abdel-Rahman M.A.M., Albano M., Mahmoud M.M. (2024). Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus): A review. Biol., 13: 914.
  5. Abdel-Latif H.M., Khalil R.H. (2014). Evaluation of two phytobiotics, Spirulina platensis and Origanum vulgare extract on growth, serum antioxidant activities and resistance of Nile tilapia (Oreochromis niloticus) to pathogenic Vibrio alginolyticus. Int. J. Fish. Aquat. Stud., 250: 250–255.
  6. Abdelsalam M., Elgendy M.Y., Elfadadny M.R., Ali S.S., Sherif A.H., Abolghait S.K. (2023). A review of molecular diagnoses of bacterial fish diseases. Aquacult. Int., 31: 417–434.
  7. Abdelsalam M., Attia M.M., Marzouk M.S., Korany R.M., Elgendy M.Y., Soliman A.W., Hamada A.H. (2024). Investigating dynamics, etiology, pathology, and therapeutic interventions of Caligus clemensi and Vibrio alginolyticus co-infection in farmed marine fish. Sci. Rep., 14: 20704.
  8. Abdel-Tawwab M., Abdel-Rahman A.M., Ismael N.E. (2008). Evaluation of commercial live bakers’ yeast, Saccharomyces cerevisiae as a growth and immunity promoter for fry Nile tilapia, Oreochromis niloticus (L.) challenged in situ with Aeromonas hydrophila. Aquaculture, 280: 185–189.
  9. Abdul Kader Mydeen K.P., Haniffa M.A. (2011). Evaluation of antibacterial activity of medicinal plants on fish pathogen Aeromonas hydrophila. Res. J. Biol., 1: 1–5.
  10. Abdullah S., Omar, N., Yusoff S.M., Obukwho E.B., Nwunuji T.P., Hanan L., Samad J. (2013). Clinicopathological features and immunohistochemical detection of antigens in acute experimental Streptococcus agalactiae infection in red tilapia (Oreochromis spp.). Springer Plus., 2: 1–7.
  11. Abebe E., Gugsa G., Ahmed M., Awol N., Tefera Y., Abegaz S., Sisay T. (2023). Occurrence and antimicrobial resistance pattern of E. coli O157: H7 isolated from foods of bovine origin in Dessie and Kombolcha towns, Ethiopia. PLoS Negl. Trop. Dis., 17: e0010706.
  12. Abotaleb M.M., Soliman H.M., Tawfik R.G., Mourad A., Khalil R.H., Abdel-Latif H.M. (2024). Efficacy of combined inactivated vaccines against Vibrio alginolyticus and Streptococcus agalactiae infections in Nile tilapia in Egypt. Aquac. Int., 32: 1317–1334.
  13. Aboyadak I.M., Ali N.G.M., Goda A.M.A.S., Aboelgalagel W.H., Salam A. (2015). Molecular detection of Aeromonas hydrophila as the main cause of outbreak in tilapia farms in Egypt. J. Aquac. Mar. Boil., 2: 2–5.
  14. Abu Nor N., Zamri-Saad M., Md Yasin I.S., Salleh A., Mustaffa-Kamal F., Matori M.F., Azmai M.N.A. (2020). Efficacy of whole cell inactivated Vibrio harveyi vaccine against vibriosis in a marine red hybrid tilapia (Oreochromis niloticus × O. mossambicus) model. Vaccine, 8: 734.
  15. Abu-Zahra N.I., Elseify M.M., Atia A.A., Al-Sokary E.T. (2024). Impacts of florfenicol on immunity, antioxidant activity, and histopathology of Oreochromis niloticus: a potential protective effect of dietary Spirulina platensis. Vet. Res. Commun., 48: 125–138.
  16. Alagesaboopathi C., Kalaiselvi N. (2012). Antimicrobial activities of the root, stem and leaf extracts of Argemone mexicana L. Int. J. Biosci., 2: 61–68.
  17. Alemayehu T.A., Geremew A., Getahun A. (2018). The role of functional feed additives in tilapia nutrition. Int. J. Fish. Aquac., 9: 1g–1g.
  18. Algammal A.M., Mohamed M.F., Tawfiek B.A., Hozzein W.N., El Kazzaz W.M., Mabrok M. (2020). Molecular typing, antibiogram and PCR-RFLP based detection of Aeromonas hydrophila complex isolated from Oreochromis niloticus. Pathogens, 9: 238.
  19. Algammal A.M., Mabrok M., Ezzat M., Alfifi K.J., Esawy A.M., Elmasry N., El-Tarabili R. M. (2022). Prevalence, antimicrobial resistance (AMR) pattern, virulence determinant and AMR genes of emerging multi-drug resistant Edwardsiella tarda in Nile tilapia and African catfish. Aquaculture, 548: 737643.
  20. Ali N.G., Aboyadak I.M., El-Sayed H.S. (2019). Chemotherapeutic control of Gram-positive infection in white sea bream (Diplodus sargus, Linnaeus 1758) broodstock. Vet. World., 12: 316.
  21. Aly S.M., Mohamed M.F., John G. (2008). Effect of probiotics on the survival, growth and challenge infection in Tilapia nilotica (Oreochromis niloticus). Aquac. Res., 39: 647–656.
  22. Aly S.M., Nouh W.G., Salem-Bekhit M.M. (2012). Bacteriological and histopathological studies on Enterobacteriaceae in Nile tilapia, Oreochromis niloticus. J. Pharm. Biomed. Sci., 2: 94–104.
  23. Amal M.N.A., Zamri-Saad M. (2011). Streptococcosis in tilapia (Oreochromis niloticus): a review. Pertanika J. Trop. Agric. Sci., 2795009.
  24. Amillano-Cisneros J.M., Fuentes-Valencia M.A., Leyva-Morales J.B., Savín-Amador M., Márquez-Pacheco H., Bastidas-Bastidas P.D.J., Badilla-Medina C.N. (2025). Effects of microorganisms in fish aquaculture from a sustainable approach: A review. Microorganisms, 13: 485.
  25. Amphan S., Unajak S., Printrakoon C., Areechon N. (2019). Feeding-regimen of β-glucan to enhance innate immunity and disease resistance of Nile tilapia, Oreochromis niloticus Linn., against Aeromonas hydrophila and Flavobacterium columnare. Fish. Shellfish Immunol., 87: 120–128.
  26. Anshary H., Kurniawan R.A., Sriwulan S., Ramli R., Baxa D.V. (2014). Isolation and molecular identification of the etiological agents of streptococcosis in Nile tilapia (Oreochromis niloticus) cultured in net cages in Lake Sentani, Papua, Indonesia. Springerplus, 3: 1–11.
  27. Ayoub H.F., Tohamy E.Y., Mohamed S.S. (2021). Isolation, identification and antimicrobial profile of Aeromonas spp., Pseudomonas spp. and Vibrio spp. from the Nile tilapia, Oreochromis niloticus in fish farms. EJABF, 25.
  28. Baliere C., Rincé A., Delannoy S., Fach P., Gourmelon M. (2016). Molecular profiling of Shiga toxin-producing Escherichia coli and enteropathogenic E. coli strains isolated from French coastal environments. Appl. Environ. Microbiol., 82: 3913–3927.
  29. Bernal-González K.G., Toledo-Ibarra G.A., Covantes-Rosales C.E., Barcelos-García R.G., Diaz-Resendiz K.J.G., Ventura-Ramón G.H., Girón-Pérez M.I. (2025). Proinflammatory cytokines and innate immune parameters in response to Aeromonas hydrophila in Nile tilapia (Oreochromis niloticus) exposed to diazinon, an organophosphate pesticide. Comp. Immunol. Rep., 8: 200195.
  30. Bohara K., Joshi P., Acharya K.P., Ramena G. (2024). Emerging technologies revolutionising disease diagnosis and monitoring in aquatic animal health. Rev. Aquac., 16: 836–854.
  31. Branson E.J., Diaz-Munoz D.N. (1991). Description of a new disease condition occurring in farmed coho salmon, Oncorhynchus kisutch (Walbaum), in South America. J. Fish Dis., 14: 147–156.
  32. Burr S.E., Goldschmidt-Clermont E., Kuhnert P., Frey J. (2012). Heterogeneity of Aeromonas populations in wild and farmed perch, Perca fluviatilis L. J. Fish. Dis., 35.
  33. Bwalya P., Hang’ombe B.M., Gamil A.A., Munang’andu H.M., Evensen Ø., Mutoloki S. (2020). A whole-cell Lactococcus garvieae autovaccine protects Nile tilapia against infection. PLoS ONE, 15(3): e0230739.
  34. Cai Y., Jiang L., Wang S., Zhao Z., Zhou Y., Wang S. (2024). Case of Vibrio vulnificus Infection in Orechromis niloticus during suspension of recirculating aquaculture system. Water, 16: 1878.
  35. Caruso G. (2016). Antibiotic resistance in fish farming environments: a global concern. J. Fish. Sci. Com., 10.
  36. Chan J.F.W., Woo P.C.Y., Teng J.L.L., Lau S.K.P., Leung S.S.M., Tam F.C.C., Yuen K.Y. (2011). Primary infective spondylodiscitis caused by Lactococcus garvieae and a review of human L. garvieae infections. Infection, 39: 259–264.
  37. Chitambo B., Munyeme M., Hang’ombe B. (2023). Identifying bacteria with public health significance from farmed Nile tilapia (Oreochromis niloticus), Zambia. Int. J. Microbiol., 6650378.
  38. Chiu K.H., Liu W.S. (2014). Dietary administration of the extract of Rhodobacter sphaeroides WL-APD911 enhances the growth performance and innate immune responses of seawater red tilapia (Oreochromis mossambicus × Oreochromis niloticus). Aquaculture, 418: 32–38.
  39. De Sousa E.L., Assane I.M., Santos-Filho N.A., Cilli E.M., de Jesus R.B., Pilarski F. (2021). Haematological, biochemical and immunological biomarkers, antibacterial activity, and survival in Nile tilapia Oreochromis niloticus after treatment using antimicrobial peptide LL-37 against Streptococcus agalactiae. Aquaculture, 533: 736181.
  40. Declercq A.M., Haesebrouck F., Van den Broeck W., Bossier P., Decostere A. (2013). Columnaris disease in fish: a review with emphasis on bacterium-host interactions. Vet. Res., 44: 1–17.
  41. Derome N., Gauthier J., Boutin S., Llewellyn M. (2016). Bacterial opportunistic pathogens of fish. In: The Rasputin effect: When commensals and symbionts become parasitic. Springer, pp. 81–108.
  42. Dong H.T., Chaijarasphong T., Barnes A.C., Delamare-Deboutteville J., Lee P.A., Senapin S., Bondad-Reantaso M.G. (2023). From the basics to emerging diagnostic technologies: What is on the horizon for tilapia disease diagnostics. Rev. Aquacult., 15: 186–212.
  43. Duran N., Ozer B., Duran G.G., Onlen Y., Demir C. (2012). Antibiotic resistance genes & susceptibility patterns in staphylococci. Indian J. Med. Res., 135: 389–396.
  44. Eissa A.E., Moustafa M., Abdelaziz, M., Ezzeldeen N.A. (2008). Yersinia ruckeri infection in cultured Nile tilapia, Oreochromis niloticus, at a semi-intensive fish farm in lower Egypt. Afr. J. Aquat. Sci., 33: 283–286.
  45. Eissa H.M., Khater S.I., Mohamed D.I., Fawzey M.M. (2020). Dietary omega 3 nanoparticles supplement improve growth of Nile tilapia, (Oreochromis niloticus). Egypt. J. Basic Appl. Sci., 35: 242–260.
  46. El-Araby D.A., El-Didamony G., Megahed M. (2016). New approach to use phage therapy against Aeromonas hydrophila induced motile Aeromonas septicemia (MAS), in Nile tilapia. JMSRD, 6: 2.
  47. El-Asely A.M., Abbass A.A., Austin B. (2014). Honey bee pollen improves growth, immunity and protection of Nile tilapia (Oreochromis niloticus) against infection with Aeromonas hydrophila. Fish Shellfish Immunol., 40: 500–506.
  48. El Asely A.M., Youssuf H., Abdel Gawad E., Elabd H., Matter A., Shaheen A., Abbass A. (2020). Insight into summer mortality syndrome in farmed Nile tilapia (Oreochromis niloticus) associated with bacterial infection. Benha Vet. Med. J., 39: 111–118.
  49. El-Keredy M.A., Naena N.A. (2020). Yucca plant as treatment for Pseudomonas aeruginosa infection in Nile tilapia farms with emphasis on its effect on growth performance. Alexandria J. Vet. Sci., 66: 83–94.
  50. Elavarasi K., Ranjini S., Rajagopal T., Rameshkumar G., Ponmanickam P. (2013). Bactericidal proteins of skin mucus and skin extracts from fresh water fishes, Clarias batrachus and Tilapia mossambicus. Thai J. Pharm. Sci., 37: 194–200.
  51. Elgendy M.Y., Abdelsalam M., Kenawy A., Nehal A. Younis. (2024 a). Phenotypic, genotypic and virulence traits analysis of aeromonads causing massive mortality in farmed Oreochromis niloticus. Bulletin of the European Association of Fish Pathologists, 44: 2.
  52. Elgendy M.Y., Ali S.E., Dayem A.A., Khalil R.H., Moustafa M.M., Abdelsalam M. (2024 b). Alternative therapies recently applied in controlling farmed fish diseases: mechanisms, challenges, and prospects. Aquac. Int., 32: 9017–9078.
  53. El-Gohary M.S., El Gamal A.M., Atia A.A., El-Dakroury M.F. (2020). Treatment trial of Nile tilapia (Oreochromis niloticus) experimentally infected with Vibrio alginolyticus isolated from sea bass (Dicentrarchus labrax). PJBS, 23: 1591–1600.
  54. Elhadi N., Aljeldah M., Aljindan R. (2016). Microbiological contamination of imported frozen fish marketed in Eastern Province of Saudi Arabia. Int. Food Res. J., 23: 2723.
  55. El-Houseiny W., Mansour M.F., Mohamed W.A., Al-Gabri N.A., El-Sayed A.A., Altohamy D.E., Ibrahim R.E. (2021). Silver nanoparticles mitigate Aeromonas hydrophila-induced immune suppression, oxidative stress, and apoptotic and genotoxic effects in Oreochromis niloticus. Aquaculture, 535: 736430.
  56. El-Sayed M., Algammal A., Abouel-Atta M., Mabrok M., Emam A.J.R.M.V. (2019). Pathogenicity, genetic typing, and antibiotic sensitivity of Vibrio alginolyticus isolated from Oreochromis niloticus and Tilapia zillii. Vet Med Rev., 170: 80–86.
  57. El-Tawab A., El-Hofy F., El-Gamal R., Awad S., El-Mougy E., Mohamed S. (2020). Phenotypic and genotypic characterization of antibiotic resistant strains of Flavobacterium columnare isolated from Oreochromis niloticus. BVMJ, 38: 141–145.
  58. Evans J.J., Klesius P.H., Shoemaker C.A. (2009). First isolation and characterization of Lactococcus garvieae from Brazilian Nile tilapia, Oreochromis niloticus (L.), and pintado, Pseudoplathystoma corruscans (Spix & Agassiz). J. Fish Dis., 32: 943–951.
  59. FAO (2012). Aquaculture department. The state of world fisheries and aquaculture, pp. 1–153.
  60. Fatima R. (2014). Bacteriological analysis of Nile tilapia fish (Oreochoromis niloticus). RADS J. Biol. Res. Appl. Sci., 5: 30–35.
  61. Ferrario C., Ricci G., Milani C., Lugli G.A., Ventura M., Eraclio G., Fortina M.G. (2013). Lactococcus garvieae: where is it from? A first approach to explore the evolutionary history of this emerging pathogen. PLoS One, 8(12): e84796.
  62. Figueiredo H.C.P., Nobrega Netto L., Leal C.A.G., Pereira U.P., Mian G.F. (2012). Streptococcus iniae outbreaks in Brazilian Nile tilapia (Oreochromis niloticus L.) farms. Braz. J. Microbiol., 43: 576–580.
  63. Foysal M.J., Alam M., Kawser A.R., Hasan F., Rahman M.M., Tay C.Y., Gupta S.K. (2020). Meta-omics technologies reveals beneficiary effects of Lactobacillus plantarum as dietary supplements on gut microbiota, immune response and disease resistance of Nile tilapia (Oreochromis niloticus). Aquaculture, 520: 734974.
  64. Fyrand K., Xu C., Evensen Ø. (2024). Characterization of Streptococcus agalactiae 1a isolated from farmed Nile tilapia (Oreochromis niloticus) in North America, Central America, and Southeast Asia. Fish. Shellfish. Immunol., 154: 109919.
  65. Gauthier D.T. (2015). Bacterial Zoonoses of fishes: a review and appraisal of evidence for linkages between fish and human infections. Vet. J., 203: 27–35.
  66. Ghani M.U., Chen J., Khosravi Z., Wu Q., Liu Y., Zhou J., Cui H. (2024). Unveiling the multifaceted role of toll-like receptors in immunity of aquatic animals: pioneering strategies for disease management. Front. Immunol., 15: 1378111.
  67. Gibello A., Vela A.I., Martínez-Nevado E., Rodriguez-Bertos A., Casamayor A., García J., Amaro C. (2019). Potentially human-virulent Vibrio vulnificus isolates from diseased great pompano (Trachinotus goodei). Transbound. Emerg. Dis., 66: 1765–1770.
  68. Guo M., Li C. (2021). An overview of cytokine used as adjuvants in fish: current state and future trends. Rev. Aquac., 13: 996–1014.
  69. Haenen O.L.M., Fouz B., Amaro C., Isern M.M., Zrncic S., Travers M.A., Dalsgaard I. (2014). Vibriosis in aquaculture. EAFP, 34: 138–148.
  70. Haenen O.L., Dong H.T., Hoai T.D., Crumlish M., Karunasagar I., Barkham T., Bondad-Reantaso M.G. (2023). Bacterial diseases of tilapia, their zoonotic potential and risk of antimicrobial resistance. Rev. Aquac., 15: 154–185.
  71. Hal A.M., Manal I. (2020). Gene expression and histopathological changes of Nile tilapia (Oreochromis niloticus) infected with Aeromonas hydrophila and Pseudomonas fluorescens. Aquaculture, 526: 735392.
  72. Hamad G.M., Abushaala N.M., Soltan O.I., Abdel-Hameed S.M., Magdy R.M., Ahmed E.M. H., Mahmoud S.F. (2024). Prevalence and antibacterial effect of natural extracts against Vibrio parahaemolyticus and its application on Tilapia fillets. LWT, 209: 116812.
  73. Hamada A.H., Attia M.M., Marzouk M.S., Korany R., Elgendy M.Y., Abdelsalam M. (2025). Co-infection with Caligus clemensi and Vibrio parahaemolyticus in Egyptian farmed mullets: Diagnosis, histopathology, and therapeutic management. Egypt. J. Vet. Sci., 56: 353–368.
  74. Hamid N.H., Hassan M.D., Sabri M.M., Hasliza A.H., Hamdan R.H., Afifah M.N., Fuad M. M. (2017). Studies on pathogenicity effect of Aeromonas hydrophila infection in juvenile red hybrid tilapia Oreochromis sp. In: International Seminar on Livestock Production and Veterinary Technology, pp. 532–539.
  75. Hassan S., Abdel-Rahman M., Mansour E.S., Monir W. (2020). Prevalence and antibiotic susceptibility of bacterial pathogens implicating the mortality of cultured Nile tilapia, Oreochromis niloticus. Egypt. J. Aquac., 10: 23–43.
  76. Hassan H.U., Ali Q.M., Siddique M.A.M., Hasan M.R., Hossain M.Y. (2022). Effects of dietary protein levels on growth, nutritional utilization, carcass composition and survival of Asian seabass Lates calcarifer (Bloch, 1790) fingerlings rearing in net cages. Thalassas: Int. J. Mar. Sci., pp. 1–7.
  77. Hassan H.U., Ali A., Wattoo J., Sohail M., Raza M.A., Hassan S.A., Kanwal R., Kabir M., Rafiq N., Manoharadas S., Khan M.R., Arai T. (2024). Effects of stocking density on growth performance, digestive enzyme activity, biochemical composition, and economic efficiency of a new strain of Oreochromis niloticus reared in cage culture system at Sindh Pakistan. Food Sci. Nutr., 00: 1–12.
  78. Hassan H.U., Ali A., Al Sulivany B.S., Kabir M., Kanwal R., Ahmed M.Z., Siddique M.A.M. (2025). Effects of Tribulus terrestris extract and 17 α-methyl testosterone on masculinization, growth, economic efficiency and health assessment of Nile tilapia (Oreochromis niloticus). Aquac. Int., 33: 156.
  79. Hassanin M.E., El-Murr A., El-Khattib A.R., Abdelwarith A.A., Younis E.M., Metwally M.M., Ibrahim R.E. (2024). Nano-Bacillus amyloliquefaciens as a dietary intervention in Nile tilapia (Oreochromis niloticus): Effects on resistance to Aeromonas hydrophila challenge, immune-antioxidant responses, digestive/absorptive capacity, and growth. Heliyon, 10.
  80. He Y., Wang K.Y., Xiao D., Chen D.F., Huang L., Liu T., Yang Q. (2014). A recombinant truncated surface immunogenic protein (tSip) plus adjuvant FIA confers active protection against Group B streptococcus infection in tilapia. Vaccine, 32: 7025–7032.
  81. Hernández E., Figueroa J., Iregui C. (2009). Streptococcosis on a red tilapia, Oreochromis sp., farm: a case study. J. Fish Dis., 32: 247–252.
  82. Hill C., Guarner F., Reid G. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 11: 506–514.
  83. Huicab-Pech Z.G., Landeros-Sánchez C., Castañeda-Chávez M.R., Lango-Reynoso F., López-Collado C.J., Platas Rosado D.E. (2016). Current state of bacteria pathogenicity and their relationship with host and environment in tilapia Oreochromis niloticus. J. Aquac. Res. Development., 7: 5.
  84. Huicab-Pech Z.G., Castaneda-Chavez M.R., Lango-Reynoso F. (2017). Pathogenic bacteria in Oreochromis niloticus var. Stirling tilapia culture. Int. J. Fish. Aquac., 8: 1I–1I.
  85. Ibrahim D., Pet I., Anter R.G., Abdelwarith A.A., Rahman M.M.I.A., Shafik B.M., Kishawy A.T. (2024). Marine Smenospongia extract mitigated co-infection with Trichodina sp. and Flavobacterium columnare in Nile tilapia: insights into promoting growth performance, immune, antioxidant and autophagy defenses, and suppression of endoplasmic reticulum stress-related genes. Front. Mar. Sci., 11: 1475150.
  86. Irshath A.A., Rajan A.P., Vimal S., Prabhakaran V.S., Ganesan R. (2023). Bacterial pathogenesis in various fish diseases: recent advances and specific challenges in vaccine development. Vaccines, 11: 470.
  87. Islam S.I., Ahammad F., Mohammed H. (2024). Cutting-edge technologies for detecting and controlling fish diseases: Current status, outlook, and challenges. JWAS, 55: e13051.
  88. Iwashita M.K.P., Nakandakare I.B., Terhune J.S., Wood T., Ranzani-Paiva M.J.T. (2015). Dietary supplementation with Bacillus subtilis, Saccharomyces cerevisiae and Aspergillus oryzae enhance immunity and disease resistance against Aeromonas hydrophila and Streptococcus iniae infection in juvenile tilapia Oreochromis niloticus. Fish Shellfish Immunol., 43: 60–66.
  89. Janampa-Sarmiento P.C., Costa H.L., Rosa J.C.C., Tavares G.C., Figueiredo H.C.P. (2025). Identification and phylogenetic analysis of Flavobacterium spp. associated with aquaculture fish diseased from Brazil. Pathogens, 14: 219.
  90. Jantrakajorn S., Maisak H., Wongtavatchai J. (2014). Comprehensive investigation of streptococcosis outbreaks in cultured Nile tilapia, Oreochromis niloticus, and red tilapia, Oreochromis sp., of Thailand. J. World Aquac. Soc., 45: 392–402.
  91. Jantrakajorn S., Suyapoh W., Wongtavatchai J. (2024). Characterization of Lactococcus garvieae and Streptococcus agalactiae in cultured red tilapia Oreochromis sp. in Thailand. J. Aquat. Anim. Health., 36: 192–202.
  92. Jeffery K.R., Stone D., Feist S.W., Verner-Jeffreys D.W. (2010). An outbreak of disease caused by Francisella sp. in Nile tilapia Oreochromis niloticus at a recirculation fish farm in the UK. Dis. Aquat. Organ., 91: 161–165.
  93. Jhunkeaw C., Khongcharoen N., Rungrueng N., Sangpo P., Panphut W., Thapinta A., Dong H.T. (2021). Ozone nanobubble treatment in freshwater effectively reduced pathogenic fish bacteria and is safe for Nile tilapia (Oreochromis niloticus). Aquaculture, 534: 736286.
  94. Jia K., Yang N., Zhang X., Cai R., Zhang Y., Tian J., Wang G. (2020). Genomic, morphological and functional characterization of virulent bacteriophage IME-JL8 targeting Citrobacter freundii. Front. Microbiol., 11: 585261.
  95. Kang T., Oyong G.G., Chua Cabrera E. (2020). High prevalence of carbapenem and extended spectrum β-lactam resistant Escherichia coli from tilapia (Oreochromis niloticus) from two wet markets in Metro Manila, Philippines. Malays. J. Microbiol., 16.
  96. Kebede Abdi A., Rufael T., Senbata B., Mohamed A.A. (2024). Phenotypic, molecular detection, and antibiogram analysis of Pseudomonas strain from Oreochromis niloticus. L 1758 (Nile tilapia) from aquaculture pond. Ethiopia. Res. Sq., http://dx.doi.org/10.21203/rs.3.rs-5023769/v1
  97. Khan M.L., Hassan H.U., Khan F.U., Ghaffar R.A., Rafiq N., Bilal M., Arai T. (2023). Effects of microplastics in freshwater fish’s health and the implications for human health. Braz. J. Biol., 84: e272524.
  98. Khatun H., Hossain M.D., Jahan S.N., Khanom D.A. (2011). Bacterial infestation in different fish at Rajshahi. J. Sci. Found., 9: 77–84.
  99. Kocher A. (2004). The potential for immunosaccharides to maximize growth performance. Interfacing immunity, gut health and performance. Eco. Rec. Agro., pp. 107–115.
  100. Kuebutornye F.K., Abarike E.D., Sakyi M.E., Lu Y., Wang Z. (2020). Modulation of nutrient utilization, growth, and immunity of Nile tilapia, Oreochromis niloticus: the role of probiotics. Aquac. Int., 28: 277–291.
  101. Kumar G., Menanteau-Ledouble S., Saleh M., El-Matbouli M. (2015). Yersinia ruckeri, the causative agent of enteric redmouth disease in fish. Vet. Res., 46: 1–10.
  102. Kümmerer K. (2009). Antibiotics in the aquatic environment – a review – part I. Chemosphere, 75: 417–434.
  103. Kwon S.R., Nam Y.K., Kim S.K., Kim K.H. (2006). Protection of tilapia (Oreochromis mosambicus) from edwardsiellosis by vaccination with Edwardsiella tarda ghosts. Fish Shellfish. Immunol., 20: 621–626.
  104. LaFrentz B.R., Králová S., Burbick C.R., Alexander T.L., Phillips C.W., Griffin M.J., Snekvik K.R. (2022). The fish pathogen Flavobacterium columnare represents four distinct species: Flavobacterium columnare, Flavobacterium covae sp. nov., Flavobacterium davisii sp. nov. and Flavobacterium oreochromis sp. nov., and emended description of Flavobacterium columnare. Syst. Appl. Microbiol., 45: 126293.
  105. Lara-Flores M., Olvera-Novoa M.A., Guzmán-Méndez B.E., López-Madrid W. (2003). Use of the bacteria Streptococcus faecium and Lactobacillus acidophilus, and the yeast Saccharomyces cerevisiae as growth promoters in Nile tilapia (Oreochromis niloticus). Aquaculture, 216: 193–201.
  106. Lau S.K., Teng J.L., Ho C.C., Woo P.C. (2015). Gene amplification and sequencing for bacterial identification. In: Methods in microbiology. Academic Press. 42: 433–464.
  107. Lee B.C., Hung C.W., Lin C.Y., Shih C.H., Tsai H.J. (2019). Oral administration of transgenic biosafe microorganism containing antimicrobial peptide enhances the survival of tilapia fry infected bacterial pathogen. Fish. Shellfish. Immunol., 95: 606–616.
  108. Lee P.T., Ho T.H., Nguyen B.T., Lin Y.L., Chiu P.Y. (2020). Expression profile, subcellular localization and signaling pathway analysis of fish-specific TLR25 in Nile tilapia (Oreochromis niloticus). Fish Shellfish Immunol., 104: 141–154.
  109. Li S., Xie H., Yan Z., Li B., Wu P., Qian X., Zhao X. (2019). Development of a live vector vaccine against infectious hematopoietic necrosis virus in rainbow trout. Fish. Shellfish Immunol., 89: 516–524.
  110. Li W., Wang H.Q., He R.Z., Li Y.W., Su Y.L., Li A.X. (2016). Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): insight into vaccine development. Fish. Shellfish Immunol., 55: 737–746.
  111. Liu L., Lu D.Q., Xu J., Luo H.L., Li A.X. (2019). Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture. J. Fish Dis., 42: 693–701.
  112. Lu J., Yoshizaki G., Sakai K., Takeuchi T. (2002). Acceptability of raw Spirulina platensis by larval tilapia Oreochromis niloticus. Fish Sci., 68: 51–58.
  113. Lulijwa R., Rupia E.J., Alfaro A.C. (2020). Antibiotic use in aquaculture, policies and regulation, health and environmental risks: a review of the top 15 major producers. Rev. Aquac., 12: 640–663.
  114. Ma J., Bruce T.J., Jones E.M., Cain K.D. (2019). A review of fish vaccine development strategies: conventional methods and modern biotechnological approaches. Microorganisms, 7: 569.
  115. MacAulay S., Ellison A.R., Kille P., Cable J. (2022). Moving towards improved surveillance and earlier diagnosis of aquatic pathogens: From traditional methods to emerging technologies. Rev. Aquac., 14: 1813–1829.
  116. Mahendran R., Jeyabaskar S., Sitharaman G., Michael R.D., Paul A.V. (2016). Computer-aided vaccine designing approach against fish pathogens Edwardsiella tarda and Flavobacterium columnare using bioinformatics softwares. Drug. Des. Devel. Ther., pp. 1703–1714.
  117. Martin S.A., Król E. (2017). Nutrigenomics and immune function in fish: new insights from omics technologies. Dev. Comp. Immunol., 75: 86–98.
  118. Mathew R.T., Alkhamis Y.A., Alngada R.S., Whed R.A., Aljaafari N.A., Eissa E.S.H., Abdelnour S.A. (2025). 4-octyl itaconate improves water quality, growth, immunity, blood parameters, and disease resistance of Nile tilapia (Oreochromis niloticus) infected with Aeromonas hydrophila. Aquac. Int., 33: 87.
  119. Mauel M.J., Miller D.L. (2002). Piscirickettsiosis and piscirickettsiosis-like infections in fish: a review. Vet. Microbiol., 87: 279–289.
  120. Mauel M.J., Miller D.L., Frazier K., Liggett A.D., Styer L., Montgomery-Brock D., Brock J. (2003). Characterization of a piscirickettsiosis-like disease in Hawaiian tilapia. Dis. Aquat. Organ., 53: 249–255.
  121. Mauel M.J., Miller D.L., Styer E., Pouder D.B., Yanong R.P., Goodwin A.E., Schwedler T.E. (2005). Occurrence of piscirickettsiosis-like syndrome in tilapia in the continental United States. J. Vet. Diagn. Invest., 17: 601–605.
  122. Mauel M.J., Soto, E., Moralis J.A., Hawke J. (2007). A piscirickettsiosis-like syndrome in cultured Nile tilapia in Latin America with Francisella spp. as the pathogenic agent. J. Aquat. Anim. Health., 19: 27–34.
  123. Merrifield D.L., Dimitroglou A., Foey A., Davies S.J., Baker R.T., Bøgwald J., Ringø E. (2010). The current status and future focus of probiotic and prebiotic applications for salmonids. Aquaculture, 302: 1–18.
  124. Meyer C., Shrestha R.P., Milston-Clements R., Gibson S., Heckman T.I., Yazdi Z., Soto E. (2025). Immune response of Nile tilapia (Oreochromis niloticus) vaccinated with diatom-based oral vaccines against piscine francisellosis. J. Fish Dis., e14111.
  125. Miyazaki T., Kaige N. (1985). Comparative histopathology of edwardsiellosis in fishes. Pathology, 20: 219–227.
  126. Moharam N.M., Eissa A.E., Younis N.A., Moustafa M. (2024). Mass kills associated with Pseudomonas fluorescens and Saprolegnia parasitica concurrent infection in earthen pond-farmed Nile tilapia (Oreochromis niloticus). Egyp. J. Vet. Sci., doi: 10.21608/ejvs.2024.286135.2047
  127. Molinari L.M., Scoaris D.D.O., Pedroso R.B., Bittencourt N.L.R., Nakamura C.V., Nakamura T.U., Dias Filho B.P. (2003). Bacterial microflora in the gastrointestinal tract of Nile tilapia, Oreochromis niloticus, cultured in a semi-intensive system. Acta. Sci. Biol. Sci., 25: 267–271.
  128. Mondal H., Thomas J. (2022). A review on the recent advances and application of vaccines against fish pathogens in aquaculture. Aquac. Int., 30: 1971–2000.
  129. Montaser M.M., El-Sharnouby M. E., El-Noubi G., El-Shaer H.M., Khalil A.A., Hassanin M., El-Araby D.A. (2021). Boswellia serrata resin extract in diets of Nile tilapia, Oreochromis niloticus: Effects on the growth, health, immune response, and disease resistance to Staphylococcus aureus. Animals, 11: 446.
  130. Mugwanya M., Dawood M.A., Kimera F., Sewilam H. (2021). Updating the role of probiotics, prebiotics, and synbiotics for tilapia aquaculture as leading candidates for food sustainability: a review. Probiotics Antimicrob. Proteins, 14: 130–157.
  131. Mukherjee A., Chandra G., Ghosh K. (2019). Single or conjoint application of autochthonous Bacillus strains as potential probiotics: Effects on growth, feed utilization, immunity and disease resistance in rohu, Labeo rohita (Hamilton). Aquaculture, 512: 734302.
  132. Mumbo M.T., Nyaboga E.N., Kinyua J.K., Muge E.K., Mathenge S.G., Rotich H., Njiru J.M. (2023). Antimicrobial resistance profiles of Salmonella spp. and Escherichia coli isolated from fresh Nile tilapia (Oreochromis niloticus) fish marketed for human consumption. BMC Microbiol., 23: 306.
  133. Munguti J.M., Nairuti R., Iteba J.O., Obiero K.O., Kyule D., Opiyo M.A., Ogello E.O. (2022). Nile tilapia (Oreochromis niloticus Linnaeus, 1758) culture in Kenya: Emerging production technologies and socio-economic impacts on local livelihoods. Aquac. Fish. Fish, 2: 265–276.
  134. Mutoloki S., Munang’andu H.M., Evensen Ø. (2015). Oral vaccination of fish–antigen preparations, uptake, and immune induction. Front. Immunol., 6: 519.
  135. Natnan M.E., Mayalvanan Y., Jazamuddin F.M., Aizat W.M., Low C.F., Goh H.H., Baharum S.N. (2021). Omics strategies in current advancements of infectious fish disease management. Biology, 10: 1086.
  136. Newaj-Fyzul A., Mutani A., Ramsubhag A., Adesiyun A. (2008). Prevalence of bacterial pathogens and their anti-microbial resistance in tilapia and their pond water in Trinidad. Zoonoses Public Health., 55: 206–213.
  137. Nguyen HT., Kanai K., Yoshikoshi K. (2002). Ecological investigation of Streptococcus iniae in cultured Japanese flounder (Paralichthys olivaceus) using selective isolation procedures. Aquaculture, 205: 7–17.
  138. Nguyen N.P., Warnow T., Pop M., White B. (2016). A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity. NPJ Biofilms Microbiomes., 2:1–8.
  139. Novotny L. (2021). Respiratory tract disorders in fishes. Vet. Clin. North. Am. Exot. Anim. Pract., 24: 267–292.
  140. Oh W.T., Jun J.W., Kim H.J., Giri S.S., Yun S., Kim S.G., Park S.C. (2020). Characterization and pathological analysis of a virulent Edwardsiella anguillarum strain isolated from Nile tilapia (Oreochromis niloticus) in Korea. Front. Vet. Sci., 7: 14.
  141. Oliveira H., Pinto G., Oliveira A., Oliveira C., Faustino M.A., Briers Y., Azeredo J. (2016). Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates. Appl. Microbiol. Biotechnol., 100: 10543–10553.
  142. Omar A.A., Assar D.H., Shukry M., El-Ezz A.A., Farrag F.A., Abd El-Aziz W.E., Moustafa E. M. (2025). Impact of Ecobiol Plus® feed additive on growth performance, physiological response, oxidative status and immunological status of Nile tilapia (Oreochromis niloticus) fingerlings challenged with Aeromonas hydrophila. BMC Vet. Res., 21: 1–16.
  143. Osman K.M., Al-Maary K.S., Mubarak A.S., Dawoud T.M., Moussa I.M., Ibrahim M.D., Fawzy N.M. (2017). Characterization and susceptibility of streptococci and enterococci isolated from Nile tilapia (Oreochromis niloticus) showing septicaemia in aquaculture and wild sites in Egypt. BMC Vet. Res., 13: 1–10.
  144. Osman K.M., Da Silva Pires Á., Franco O.L., Saad A., Hamed M., Naim H., Elbehiry A. (2021). Nile tilapia (Oreochromis niloticus) as an aquatic vector for Pseudomonas species of medical importance: Antibiotic resistance association with biofilm formation, quorum sensing and virulence. Aquaculture, 532: 736068.
  145. Osorio C.R., Barja J.L., Hutson R.A., Collins M.D. (1999). Note: Arthrobacter rhombi sp. nov., isolated from Greenland halibut (Reinhardtius hippoglossoides). Int. J. Syst. Evol. Microbiol., 49: 1217–1220.
  146. Ottem K.F., Nylund A., Karlsbakk E., Friis-Møller A., Krossøy B., Knappskog D. (2007). New species in the genus Francisella (Gammaproteobacteria; Francisellaceae); Francisella piscicida sp. nov. isolated from cod (Gadus morhua). Arch. Microbiol., 188: 547–550.
  147. Paredes-Trujillo A.I., Mendoza-Carranza M. (2024). Streptococcosis in Nile tilapia farming: A severe yet overlooked health challenge in Mexico, a study case in Campeche, Mexico. Bull. Eur. Assoc. Fish Pathol., https://doi.org/10.48045/001c.131920
  148. Park S.B., Aoki T., Jung T.S. (2012). Pathogenesis of and strategies for preventing Edwardsiella tarda infection in fish. Vet. Res., 43: 1–11.
  149. Parthasarathy R., Ramasubramanian V., Ravi D. (2012). Effect of probiotic bacteria as a biocontrol agent against disease causing pathogen in Catla catla (Hamilton, 1822). Int. J. Curr. Res., 4: 15.
  150. Pirarat N., Kobayashi T., Katagiri T., Maita M., Endo M. (2006). Protective effects and mechanisms of a probiotic bacterium Lactobacillus rhamnosus against experimental Edwardsiella tarda infection in tilapia (Oreochromis niloticus). Vet. Immunol. Immunopathol., 113: 339–347.
  151. Pridgeon J.W., Klesius P.H. (2012). Major bacterial diseases in aquaculture and their vaccine development. Anim. Sci. Rev., 7: 1–16.
  152. Pridgeon J.W., Klesius P. H. (2013). Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin. Vaccine, 31: 2705–2712.
  153. Pulpipat T., Lin K.H., Chen Y.H., Wang P.C., Chen S.C. (2019). Molecular characterization and pathogenicity of Francisella noatunensis subsp. orientalis isolated from cultured tilapia (Oreochromis sp.) in Taiwan. J. Fish Dis., 42: 643–655.
  154. Rahman A.N.A., Mahboub H.H., Elshopakey G.E., Darwish M.I., Gharib H.S.A.R., Shaalan M., Elsheshtawy H.M. (2024). Pseudomonas putida infection induces immune-antioxidant, hepatorenal, ethological, and histopathological/immunohistochemical disruptions in Oreochromis niloticus: the palliative role of titanium dioxide nanogel. BMC Vet. Res., 20: 127.
  155. Rajme-Manzur D., Hernández-López J., Martínez-Porchas M., Vargas-Albores F., Garibay-Valdez E., Coronado-Molina D.E., Santacruz A. (2023). Staphylococcus haemolyticus and Providencia vermicola infections occurring in farmed tilapia: Two potentially emerging pathogens. J. Anim., 13: 3715.
  156. Rathor G.S., Swain B. (2024). Advancements in fish vaccination: Current innovations and future horizons in aquaculture health management. Appl. Sci., 14: 5672.
  157. Rattanachaikunsopon P., Phumkhachorn P. (2010 a). Potential of cinnamon (Cinnamomum verum) oil to control Streptococcus iniae infection in tilapia (Oreochromis niloticus). Fish. Sci., 76: 287–293.
  158. Rattanachaikunsopon P., Phumkhachorn P. (2010 b). Use of Asiatic pennywort Centella asiatica aqueous extract as a bath treatment to control columnaris in Nile tilapia. J. Aquat. Anim. Health., 22: 14–20.
  159. Riauwaty M., Siregar Y.I., Mulyani I. (2021). Effectiveness of turmeric-enriched pellets to improve the immunity of Clarias batrachus toward motile Aeromonas septicemia disease. F1000Res., 10.
  160. Ridha M.T., Azad I.S. (2012). Preliminary evaluation of growth performance and immune response of Nile tilapia Oreochromis niloticus supplemented with two putative probiotic bacteria. Aquac. Res., 43: 843–852.
  161. Ringø E., Olsen R.E., Gifstad T.Ø., Dalmo R.A., Amlund H., Hemre G.I., Bakke A.M. (2010). Prebiotics in aquaculture: a review. Aquac. Nutr., 16: 117–136.
  162. Rivas A.V., Dos Santos A.G.V., De Souza A.B., Bueno Junior G., De Souza G.F., De Souza E.M., Viana K.F. (2023). Bivalent vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile tilapia (Oreochromis niloticus): a laboratory-phase and large-scale study. Animals, 13: 3338.
  163. Rocha R.D.S., Leite L.O., Sousa O.V.D., Vieira R.H.S.D.F. (2014). Antimicrobial susceptibility of Escherichia coli isolated from fresh-marketed Nile tilapia (Oreochromis niloticus). J. Pathog., 756539.
  164. Roque A., Soto-Rodríguez S.A., Gomez-Gil B. (2009). Bacterial fish diseases and molecular tools for bacterial fish pathogens detection. AQMBiol., 1: 73–99.
  165. Rutherfurd-Markwick K.J., Gill H.S. (2004). Probiotics and immunomodulation. In: Diet and human immune function. Totowa, NJ: Humana Press, pp. 327–344.
  166. Saleh O., Mohamed M., Abd El-Galil M.A.E.A., El-Kamed A., Sayed H. (2021). Isolation and characterization of Micrococcus luteus from Oreochromis niloticus in Egypt. J. Curr. Vet. Res., 2: 16–23.
  167. Sanyal K.B., Mukherjee D., Guchhait A., Dash G. (2018). Phenotypic and molecular identification of bacterial species in Indian major carps and exotic carps from south 24 Parganas, West Bengal, India. Int. J. Curr. Microbiol. Appl. Sci., 7: 534–547.
  168. Saqr S., Khaliel R., Ibrahim M.S. (2016). Antibiotic resistance and virulence genes of E. coli isolated from fresh Nile tilapia (Oreochromis niloticus) in El-Behera Governorate, Egypt. Alex. J. Vet. Sci., 48.
  169. Sebastião F.A., Nomura D., Sakabe R., Pilarski F. (2011). Hematology and productive performance of Nile tilapia (Oreochromis niloticus) naturally infected with Flavobacterium columnare. Braz. J. Microbiol., 42: 282–289.
  170. Selim K.M., Reda R.M. (2015). Improvement of immunity and disease resistance in the Nile tilapia, Oreochromis niloticus, by dietary supplementation with Bacillus amyloliquefaciens. Fish. Shellfish Immunol., 44: 496–503.
  171. Shabirah A., Mulyani Y., Lili W. (2019). Effect of types isolated lactic acid bacteria on hematocrit and differential leukocytes fingerling common carp (Cyprinus carpio L.) infected with Aeromonas hydrophila bacteria. World News Nat. Sci., 24.
  172. Shahin K., Shinn A.P., Metselaar M., Ramirez-Paredes J.G., Monaghan S.J., Thompson K.D., Adams A. (2019). Efficacy of an inactivated whole-cell injection vaccine for Nile tilapia, Oreochromis niloticus (L), against multiple isolates of Francisella noatunensis subsp. orientalis from diverse geographical regions. Fish Shellfish Immunol., 89: 217–227.
  173. Sharon J., Abraham T.J., Sen A., Das R., Sinha P., Boda S., Patil P.K. (2025). Haemato-biochemistry, erythromorphology, and histopathology of Oreochromis niloticus as influenced by Aeromonas hydrophila infection and florfenicol therapy. Anim. Res. One Health, 3: 54–70.
  174. Sherif A.H., Gouda M.Y., Al-Sokary E.T., Elseify M.M. (2021). Lactobacillus plantarum enhances immunity of Nile tilapia Oreochromis niloticus challenged with Edwardsiella tarda. Aquac. Res., 52: 1001–1012.
  175. Shivam S., El-Matbouli M., Kumar G. (2021). Development of fish parasite vaccines in the OMICs era: Progress and opportunities. Vaccines, 9: 179.
  176. Siamujompa M., Ndashe K., Zulu F.C., Chitala C., Songe M.M., Changula K., Hang’ombe B.M. (2023). An investigation of bacterial pathogens associated with diseased Nile tilapia in small-scale cage culture farms on Lake Kariba, Siavonga, Zambia. Fishes, 8: 452.
  177. Sierralta V., Mayta E., León J., Serna J., Robles C., Alfaro R. (2020). Caracterización histológica y molecular de infección por Edwardsiella anguillarum en tilapia (Oreochromis niloticus) cultivada en sistema biofloc en Lima, Perú. Revista de Investigaciones Veterinarias del Perú, 31.
  178. Soliman M.K., Ellakany H.F., Gaafar A.Y., Elbialy A.K., Zaki M.S., Younes A.M. (2014). Epidemiology and antimicrobial activity of methicillin-resistant Staphylococcus aureus (MRSA) isolated from Nile tilapia (Oreochromis niloticus) during an outbreak in Egypt. Life Sci. J., 11: 1245–1252.
  179. Soto E., Hawke J.P., Fernandez D., Morales J. (2009). Francisella sp., an emerging pathogen of tilapia, Oreochromis niloticus (L.), in Costa Rica. J. Fish Dis., 32: 713–722.
  180. Soto E., Shahin K., Talhami J.J., Griffin M.J., Adams A., Ramírez-Paredes J.G. (2019). Characterization of Francisella noatunensis subsp. orientalis isolated from Nile tilapia Oreochromis niloticus farmed in Lake Yojoa, Honduras. Dis. Aquat. Organ., 133: 141–145.
  181. Starliper C.E. (2011). Bacterial coldwater disease of fishes caused by Flavobacterium psychrophilum. J. Adv. Res., 2: 97–108.
  182. Storms V., Devriese L.A., Coopman R., Schumann P., Vyncke F., Gillis M. (2003). Arthrobacter gandavensis sp. nov., for strains of veterinary origin. Int. J. Syst. Evol. Microbiol., 53: 1881–1884.
  183. Sudhakar K., Dathu R.P., Naidu Y.P. (2025). Current trends, innovative advancements and future prospects of fish vaccination: preventive and control strategies of vaccines against infectious diseases in fish. J. Exp. Zool. India., 28.
  184. Sughra F., Abbas F., Altaf I., Muhammad A. (2021). Phenotypic characterization, genetic analysis and antibiotic sensitivity of Aeromonas hydrophila isolates causing abdominal dropsy in Labeo rohita collected from Punjab, Pakistan. J. Fish., 10.
  185. Suresh K., Pillai D., Soni M., Rathlavath S., Narshivudu D. (2025). Micrococcus luteus, an emerging opportunistic pathogen in farmed Nile tilapia, Oreochromis niloticus in Andhra Pradesh, India. Aquac. Int., 33: 51.
  186. Syed R., Masood Z., Hassan H.U., Khan W., Mushtaq S., Ali A., Ullah A. (2022). Growth performance, haematological assessment and chemical composition of Nile tilapia, Oreochromis niloticus (Linnaeus, 1758) fed different levels of Aloe vera extract as feed additives in a closed aquaculture system. Saudi J. Biol. Sci., 29: 296–303.
  187. Takyi R., Nunoo F.K.E., Ziddah P., Oddoye J. (2012). Occurrence of bacterial infection in two commonly cultured fish species on two fish farms in southern Ghana. J. Biol. Res., 5: 81–92.
  188. Taoka Y., Maeda H., Jo J.Y., Kim S.M., Park S.I., Yoshikawa T., Sakata T. (2006). Use of live and dead probiotic cells in tilapia Oreochromis niloticus. Fish Sci., 72: 755–766.
  189. Telli G.S., Ranzani-Paiva M.J.T., De Carla Dias D., Sussel F.R., Ishikawa C.M., Tachibana L. (2014). Dietary administration of Bacillus subtilis on hematology and non-specific immunity of Nile tilapia Oreochromis niloticus raised at different stocking densities. Fish. Shellfish. Immunol., 39: 305–311.
  190. Thanh H.N., Thuy H.L., Gallardo W.G., Thanh H.N. (2014). Bacterial population in intensive tilapia (Oreochromis niloticus) culture pond sediment in Hai Duong province, Vietnam. Int. J. Fish. Aquac., 6: 133–139.
  191. Thanigaivel S., Vijayakumar S., Gopinath S., Mukherjee A., Chandrasekaran N., Thomas J. (2015). In vivo and in vitro antimicrobial activity of Azadirachta indica (Lin) against Citrobacter freundii isolated from naturally infected tilapia (Oreochromis mossambicus). Aquaculture, 437: 252–255.
  192. Toranzo A.E., Magariños B., Romalde J.L. (2005). A review of the main bacterial fish diseases in mariculture systems. Aquaculture, 246: 37–61.
  193. Tsai M.A., Wang P.C., Cao T.T., Liao P.C., Liaw L.L., Chen S.C. (2013). Immunoprotection of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Lactococcus garvieae against lactococcosis in tilapia. J. Gen. Appl. Microbiol., 59: 437–449.
  194. Ujan J.A., Rind K.H., Kesbiç O.S., Masud S., Habib S.S., Al-Rejaie S.S., Fazio F. (2025). Green boost for Nile tilapia, Oreochromis niloticus: Unveiling the multifaceted effects of Chenopodium album leaves powder on growth, hematology, antioxidant defense, nonspecific immunity and tolerance against Aeromonas hydrophila. Aquac. Res., 8919050.
  195. Vaneci-Silva D., Ferreira D.D.A.R., Do Vale Oliveira A., De Sousa E.L., Gomes F.C., Assane I.M., Pilarski F. (2025). Therapeutic potential of bioactive peptides against Lactococcus petauri in Nile tilapia. Microb. Pathog., 07348.
  196. Verdegem M., Buschmann A.H., Latt U.W., Dalsgaard A.J., Lovatelli A. (2023). The contribution of aquaculture systems to global aquaculture production. JWAS, 54: 206–250.
  197. Verschuere L., Rombaut G., Sorgeloos P., Verstraete W. (2000). Probiotic bacteria as biological control agents in aquaculture. Microbiol. Mol. Biol., 64: 655–671.
  198. Wamala S.P., Mugimba K.K., Mutoloki S., Evensen Ø., Mdegela R., Byarugaba D.K., Sørum H. (2018). Occurrence and antibiotic susceptibility of fish bacteria isolated from Oreochromis niloticus (Nile tilapia) and Clarias gariepinus (African catfish) in Uganda. Fish. Aquat. Sci., 21: 1–10.
  199. Wang B., Thompson K.D., Wangkahart E., Yamkasem J., Bondad-Reantaso M.G., Tattiyapong P., Surachetpong W. (2023). Strategies to enhance tilapia immunity to improve their health in aquaculture. Rev. Aquacult., 15: 41–56.
  200. Wang Q., Zhang C., Xu L., Chen J., Wang X. (2021). Characterization of Streptococcus iniae ghost vaccine and its immunization in Nile tilapia (Oreochromis niloticus). Aquac. Res., 52: 1359–1368.
  201. Wanja D.W., Mbuthia P.G., Waruiru R.M., Mwadime J.M., Bebora L.C., Nyaga P.N., Ngowi H.A. (2020). Fish husbandry practices and water quality in central Kenya: potential risk factors for fish mortality and infectious diseases. Vet. Med. Int., 2020: 6839354.
  202. Wongkaew J., Chatchaiphan S., Taengphu S., Dong H.T., Senapin S., Piyapattanakorn S. (2025). Identification and pathogenicity of Lactococcus species in Nile tilapia (Oreochromis niloticus) and Asian sea bass (Lates calcarifer). J. Fish Dis., e14113.
  203. Xu M., Li F., Chen B., Deng Y., Chen D., Geng Y., Huang X. (2025). Isolation, identification and histopathological observation of Francisella noatunensis subsp. orientalis from Nile tilapia (Oreochromis niloticus). Aquaculture, 595: 741532.
  204. Yardimci B., Aydin Y. (2011). Pathological findings of experimental Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus). Ankara Univ. Vet. Fak. Derg., 58: 47–54.
  205. Younes A.M., Fares M.O., Gaafar A.Y., Mohamed L.A. (2016). Isolation of Vibrio alginolyticus and Vibrio vulnificus strains from cultured Oreochromis niloticus around Qarun Lake, Egypt. Glob. Vet., 16: 01–05.
  206. Yue G., Guo C. (2025). Strategies for managing major diseases in Asian seabass aquaculture. Anim Dis., 5: 6.
  207. Zahran E., Risha E. (2013). Protective role of adjuvant and potassium permanganate on oxidative stress response of Nile tilapia (Oreochromis niloticus) challenged with Saprolegnia ferax. Springer-Plus, 2: 1–10.
  208. Zein-Eddine R., Nasser N., Kassem I., Saoud I.P. (2022). Effect of the human probiotic bacterium Escherichia coli Nissle 1917 on performance and immune response of Nile tilapia Oreochromis niloticus. J. Appl. Aquacult., 34: 527–541.
  209. Zeng W., Wang Y., Hu H., Wang Q., Bergmann S.M., Wang Y., Li Y. (2021). Cell culture-derived tilapia lake virus-inactivated vaccine containing montanide adjuvant provides high protection against viral challenge for tilapia. Vaccines, 9: 86.
  210. Zhu J., Li C., Ao Q., Tan Y., Luo Y., Guo Y., Gan X. (2015). Trancriptomic profiling revealed the signatures of acute immune response in tilapia (Oreochromis niloticus) following Streptococcus iniae challenge. Fish Shellfish Immunol., 46: 346–353.
DOI: https://doi.org/10.2478/aoas-2025-0046 | Journal eISSN: 2300-8733 | Journal ISSN: 1642-3402
Language: English
Page range: 211 - 235
Submitted on: Oct 10, 2024
|
Accepted on: Apr 29, 2025
|
Published on: Jan 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2026 Muhammad Luqman Khan, Habib Ul Hassan, Shahnaz Rashid, Sumbul, Ghazi Alatawi, Ghulam Abbas, Muhammad Ahsan Raza, Rizwana Abdul Ghaffar, Roohi Kanwal, Muhammad Kabir, Naseem Rafiq, Mary Mahwish, Yousef Abdal Jalil Fadladdin, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution 3.0 License.